HK1257222A1 - 經巴氏滅菌的艾克曼菌用於治療代謝病症的用途 - Google Patents

經巴氏滅菌的艾克曼菌用於治療代謝病症的用途

Info

Publication number
HK1257222A1
HK1257222A1 HK18116227.1A HK18116227A HK1257222A1 HK 1257222 A1 HK1257222 A1 HK 1257222A1 HK 18116227 A HK18116227 A HK 18116227A HK 1257222 A1 HK1257222 A1 HK 1257222A1
Authority
HK
Hong Kong
Prior art keywords
metabolic disorders
treating metabolic
pasteurized akkermansia
akkermansia
pasteurized
Prior art date
Application number
HK18116227.1A
Other languages
English (en)
Inventor
Patrice Cani
Amandine Everard
Hubert Plovier
Céline Druart
Vos Willem De
Clara Belzer
Original Assignee
Univ Catholique Louvain
Univ Wageningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54145609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1257222(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Catholique Louvain, Univ Wageningen filed Critical Univ Catholique Louvain
Publication of HK1257222A1 publication Critical patent/HK1257222A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
HK18116227.1A 2015-09-10 2018-12-18 經巴氏滅菌的艾克曼菌用於治療代謝病症的用途 HK1257222A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15184758 2015-09-10
PCT/EP2016/071327 WO2017042347A1 (en) 2015-09-10 2016-09-09 Use of pasteurized akkermansia for treating metabolic disorders

Publications (1)

Publication Number Publication Date
HK1257222A1 true HK1257222A1 (zh) 2019-10-18

Family

ID=54145609

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18116227.1A HK1257222A1 (zh) 2015-09-10 2018-12-18 經巴氏滅菌的艾克曼菌用於治療代謝病症的用途

Country Status (17)

Country Link
US (2) US10736924B2 (zh)
EP (3) EP3943093A1 (zh)
JP (2) JP6954563B2 (zh)
KR (4) KR20230125340A (zh)
CN (2) CN114276960A (zh)
AU (2) AU2016319221B2 (zh)
BR (1) BR112018004532B1 (zh)
CA (1) CA2998039A1 (zh)
DK (2) DK3626081T3 (zh)
EA (1) EA201800199A1 (zh)
ES (2) ES2883231T3 (zh)
HK (1) HK1257222A1 (zh)
IL (1) IL257978B (zh)
MX (1) MX2018002990A (zh)
PL (2) PL3347030T3 (zh)
PT (2) PT3626081T (zh)
WO (1) WO2017042347A1 (zh)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
ES2905525T3 (es) 2015-05-06 2022-04-11 Snipr Tech Ltd Alteración de poblaciones microbianas y modificación de la microbiota
BR112017023751A2 (pt) 2015-05-06 2018-07-31 Wageningen Universiteit uso de um polipeptídeo para efetuar a sinalização imune e/ou afetar a função de barreira intestinal e/ou condição metabólica modular
DK3626081T3 (da) * 2015-09-10 2022-02-28 Univ Catholique Louvain Pasteuriseret akkermansia til fremme af vægttab
US11202807B2 (en) * 2016-04-11 2021-12-21 Wageningen Universiteit Bacterial species
GB201609811D0 (en) 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
EP3606325A4 (en) 2017-04-03 2021-01-20 Gusto Global, LLC RATIONAL DESIGN OF BIOTHERAPEUTICS BASED ON MICROBES
TWI636788B (zh) * 2017-08-28 2018-10-01 長庚生物科技股份有限公司 戈氏副擬桿菌用於抑制脂肪肝疾病之用途
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
EP3690026A4 (en) 2017-09-28 2021-06-23 Kobiolabs, Inc. COMPOSITION FOR THE DIAGNOSIS AND TREATMENT OF ALCOHOLIC LIVER DISEASE USING A MODIFICATION IN THE SHORT CHAIN FATTY ACID-PRODUCING INTESTINAL COMMUNITY
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
EP3773645A4 (en) 2018-04-10 2021-11-24 Siolta Therapeutics, Inc. MICROBIAL CONSORTIA
KR102377407B1 (ko) * 2018-10-01 2022-03-22 한국생명공학연구원 아커만시아 뮤시니필라 균주 또는 이의 배양물을 유효성분으로 함유하는 노화방지용 조성물
KR102197180B1 (ko) * 2018-10-11 2020-12-31 주식회사 고바이오랩 아커만시아 뮤시니필라 균주 및 이를 포함하는 식욕 억제 및 대사성 질환 예방, 개선, 완화 및 치료용 조성물
CN109259240A (zh) * 2018-10-12 2019-01-25 人和未来生物科技（长沙）有限公司 调节肠道菌群和防治肥胖的组合物及其应用
US11851663B2 (en) 2018-10-14 2023-12-26 Snipr Biome Aps Single-vector type I vectors
FR3099054A1 (fr) * 2019-07-24 2021-01-29 Institut National De La Recherche Agronomique (Inra) Souche de Christensenella pour son utilisation dans le traitement et la prévention d’une inflammation gastro-intestinale
WO2020226438A1 (ko) * 2019-05-07 2020-11-12 한국생명공학연구원 염증성 장질환의 예방 또는 치료용 펩타이드
KR102128289B1 (ko) * 2019-08-23 2020-06-30 주식회사 엔테로바이옴 아커만시아 뮤시니필라 eb-amdk27 균주 및 그의 용도
KR102128287B1 (ko) * 2019-08-23 2020-06-30 주식회사 엔테로바이옴 아커만시아 뮤시니필라 eb-amdk19 균주 및 그의 용도
CN110679949A (zh) * 2019-09-30 2020-01-14 山东晶辉生物技术有限公司 一种减肥组合物及其制备方法
KR102397916B1 (ko) * 2019-10-01 2022-05-17 (주)헬스바이옴 건강한 임산부 모유 유래 혐기성 인체 균주 및 이를 이용한 대사성 질환의 예방 또는 치료방법
CA3153884A1 (en) 2019-10-07 2021-04-15 Nikole KIMES Therapeutic pharmaceutical compositions
CN110786376A (zh) * 2019-11-07 2020-02-14 中南大学湘雅医院 嗜黏蛋白艾克曼氏灭活菌在制备酸奶中的应用及酸奶的制备方法和应用
AU2020412484A1 (en) * 2019-12-23 2022-08-18 Pendulum Therapeutics, Inc. Compositions comprising microbes and methods of use and making thereof
WO2021203081A1 (en) * 2020-04-03 2021-10-07 Dupont Nutrition Biosciences Aps Composition comprising eubacterium eligens dsm 33458, intestinimonas massiliensis dsm 33460, prevotella copri dsm 33457 and/or akkermansia dsm 33459
EP4141023A4 (en) 2020-04-24 2024-05-22 Kobiolabs, Inc. PROTEIN VARIANT WITH GLP-1-INDUCING ACTIVITY AND USE THEREOF
KR102309911B1 (ko) * 2020-05-11 2021-10-07 재단법인 아산사회복지재단 신규한 아커만시아 뮤시니필라 ak32 균주의 발견 및 장 손상의 예방 또는 치료를 위한 응용
KR102185827B1 (ko) * 2020-08-26 2020-12-03 주식회사 엔테로바이옴 아커만시아 뮤시니필라 균주를 포함하는 아토피성 질환 예방 또는 치료용 약학적 조성물
BE1028339B1 (fr) 2020-11-09 2021-12-21 A Mansia Biotech Composition comprenant de l'Akkermansia muciniphila et de l'extrait de thé vert
BE1028330B1 (fr) * 2020-11-09 2021-12-17 A Mansia Biotech Composition comprenant de l'Akkermansia muciniphila et de l'extrait de camu camu
CN113041214A (zh) * 2021-03-16 2021-06-29 中南大学湘雅医院 一种负载嗜粘蛋白-艾克曼菌的改性透明质酸水凝胶及其制备方法和应用
CN113116936A (zh) * 2021-04-02 2021-07-16 上海市第六人民医院 嗜黏蛋白艾克曼氏菌在制备β-鹅脱氧胆酸抑制剂中的应用
CN113265359A (zh) * 2021-05-26 2021-08-17 广西壮族自治区兽医研究所 一种改良的嗜黏蛋白阿克曼氏菌液体培养方法
BE1029502B1 (fr) 2021-08-19 2023-01-17 The Akkermansia Company Composition comprenant de l'Akkermansia muciniphila pasteurisée pour le traitement ou la prévention de l'anxiété liée au syndrome du côlon irritable
BE1029496B1 (fr) 2021-08-19 2023-01-16 The Akkermansia Company Composition comprenant de l'Akkermansia muciniphila pasteurisée pour le traitement ou la prévention des troubles de la contractilité intestinale, en particulier des troubles de l'amplitude de la contractilité duodénale
FR3129831A1 (fr) 2021-12-07 2023-06-09 Activ'inside Utilisation d’une composition à base de Crocus sativus comme prébiotique
CN114949002B (zh) * 2022-06-08 2024-03-19 广州知易生物科技有限公司 嗜粘蛋白阿克曼菌在制备防治动脉粥样硬化的组合物中的应用
CN114949003B (zh) * 2022-06-08 2024-03-19 广州知易生物科技有限公司 嗜粘蛋白阿克曼菌及其应用和培养方法
CN115612635A (zh) * 2022-06-23 2023-01-17 济南大学 一种嗜黏蛋白艾克曼菌ww001及其组合物、复合菌剂与应用
CN116925975B (zh) * 2023-08-18 2024-01-23 善恩康生物科技（苏州）有限公司 一种Akkermansia muciniphila及其产品和应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003303894A1 (en) * 2003-01-30 2004-08-30 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
ES2561629T3 (es) * 2005-09-28 2016-02-29 Nordisk Rebalance A/S Tratamiento del SII usando como efectores de tratamiento tanto bacterias probióticas como cereales fermentados
US20100172874A1 (en) 2006-12-18 2010-07-08 The Washington University Gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
EP2030623A1 (en) 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
FR2944524B1 (fr) 2009-04-17 2012-11-30 Ipsen Pharma Sas Derives d'imidazolidine-2,4-dione et leur utilisation comme medicament
ES2559008T3 (es) * 2009-05-11 2016-02-10 Nestec S.A. Bifidobacterium longum NCC2705 no replicante y trastornos inmunitarios
WO2011088425A2 (en) * 2010-01-15 2011-07-21 The Regents Of The University Of California Electro-autotrophic synthesis of higher alcohols
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
EP2449887B1 (en) * 2010-11-05 2016-01-06 Nestec S.A. Method for preparing pet food containing probiotic micro-organisms
BR112013011733A2 (pt) * 2010-11-11 2016-07-26 Nestec Sa preparações de iorgurte consistentes contendo micro-organismos probióticos não replicativos
JP5813976B2 (ja) * 2011-03-29 2015-11-17 ユニ・チャーム株式会社 ペット用おむつ
WO2012170478A2 (en) * 2011-06-06 2012-12-13 The University Of North Carolina At Chapel Hill Methods and kits for detecting adenomas, colorectal cancer, and uses thereof
CN110201003A (zh) * 2012-02-29 2019-09-06 伊西康内外科公司 微生物区系的组合物及与其相关的方法
WO2014007606A1 (en) * 2012-07-05 2014-01-09 N.V. Nutricia Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
CN104540962B (zh) * 2012-08-01 2017-09-19 深圳华大基因研究院 糖尿病生物标志物及其应用
WO2014075745A1 (en) * 2012-11-19 2014-05-22 Université Catholique de Louvain Use of akkermansia for treating metabolic disorders
US20160120915A1 (en) * 2013-06-10 2016-05-05 New York University Methods for manipulating immune responses by altering microbiota
CN107771083A (zh) * 2015-04-23 2018-03-06 卡莱多生物科技有限公司 聚糖治疗剂和治疗方法
BR112017023751A2 (pt) * 2015-05-06 2018-07-31 Wageningen Universiteit uso de um polipeptídeo para efetuar a sinalização imune e/ou afetar a função de barreira intestinal e/ou condição metabólica modular
DK3626081T3 (da) * 2015-09-10 2022-02-28 Univ Catholique Louvain Pasteuriseret akkermansia til fremme af vægttab
US10537597B2 (en) * 2015-10-05 2020-01-21 Schweizerisches Forschungsinstitut Fur Hochgebrigsklima Und Medizin In Davos Use of Akkermansia muciniphila for treating inflammatory conditions
KR20230031895A (ko) * 2020-07-01 2023-03-07 바게닝겐 유니버시테이트 면역 신호 전달 및/또는 장관 장벽 기능 및/또는 대사 상태 조절용 Amuc-1100 폴리펩타이드 변이체(polypeptide variants)
CN113862193B (zh) * 2021-10-28 2023-12-22 江西普瑞森基因科技有限公司 一株嗜黏蛋白阿克曼氏菌及其在制备抗肿瘤药物中的应用

Also Published As

Publication number Publication date
DK3347030T3 (da) 2021-08-09
EP3943093A1 (en) 2022-01-26
PL3626081T3 (pl) 2022-04-25
CN114276960A (zh) 2022-04-05
US10736924B2 (en) 2020-08-11
EP3626081B1 (en) 2022-02-09
AU2022203731A1 (en) 2022-06-23
EP3347030A1 (en) 2018-07-18
KR102530852B1 (ko) 2023-05-12
JP6954563B2 (ja) 2021-10-27
AU2016319221A1 (en) 2018-03-29
PL3347030T3 (pl) 2021-11-22
KR20230070053A (ko) 2023-05-19
CN108289918B (zh) 2022-01-18
IL257978B (en) 2021-12-01
JP2019500004A (ja) 2019-01-10
DK3626081T3 (da) 2022-02-28
ES2908310T3 (es) 2022-04-28
KR20180053336A (ko) 2018-05-21
EP3626081A1 (en) 2020-03-25
JP2022000040A (ja) 2022-01-04
EA201800199A1 (ru) 2018-12-28
ES2883231T3 (es) 2021-12-07
MX2018002990A (es) 2018-06-08
CA2998039A1 (en) 2017-03-16
BR112018004532B1 (pt) 2022-03-15
KR102581908B1 (ko) 2023-09-22
WO2017042347A1 (en) 2017-03-16
BR112018004532A2 (pt) 2018-12-11
IL257978A (en) 2018-05-31
KR20220148941A (ko) 2022-11-07
CN108289918A (zh) 2018-07-17
EP3347030B1 (en) 2021-07-14
KR20230125340A (ko) 2023-08-29
KR102569754B1 (ko) 2023-08-23
US20210015876A1 (en) 2021-01-21
PT3626081T (pt) 2022-02-25
US20180250347A1 (en) 2018-09-06
PT3347030T (pt) 2021-08-19
AU2016319221B2 (en) 2022-06-30

Similar Documents

Publication Publication Date Title
HK1257222A1 (zh) 經巴氏滅菌的艾克曼菌用於治療代謝病症的用途
IL285151A (en) Methods for the treatment of fgf21-related disorders
IL251066A0 (en) Preparations and methods for the treatment of metabolic disorders
ZA201700311B (en) Compositions and methods of use for treating metabolic disorders
IL259861A (en) Methods and preparations for the treatment of disorders related to seizures
IL258593B (en) Compounds for the treatment of subculture disorders
GB201408387D0 (en) Treatment of respiratory disorders
SG11201708181RA (en) Methods for the treatment of inflammatory disorders
GB201612043D0 (en) Composition for treatment of disorders
GB201607388D0 (en) Treatment of impulsivity-related disorders
EP3200795A4 (en) Use of agents for treating fat-related disorders
HK1250624A1 (zh) 用於治療心血管障礙的方法
GB201602784D0 (en) New treatment of CFTR-related disorders
GB201506228D0 (en) Methods For The Treatment Of Cardivascular Disorders
GB201521542D0 (en) Methods for the treatment of cardiovascular disorders
GB201521543D0 (en) Methods for the treatment of inflammatory disorders
GB201516418D0 (en) Treatment of acute inflammatory disorders
GB201516140D0 (en) Treatment of acute inflammatory disorders
GB201513991D0 (en) Methods for the treatment of cardiovascular disorders
GB201513993D0 (en) Methods for the treatment of inflammatory disorders
GB201513344D0 (en) Methods for the treatment of Cardiovascular disorders
GB201513345D0 (en) Methods for the treatment of Inflammatory disorders
GB201507109D0 (en) Methods for the treatment of cardiovascular disorders
GB201507113D0 (en) Methods for the treatment of inflammatory disorders
GB201506419D0 (en) Methods for the treatment of inflammatory disorders